Who is speaking

Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.

If you have a cutting edge case study or a presentation and would like to join the speaker panel at one of our events, please contact Cerlin Roberts at c.roberts@oxfordglobal.co.uk

2015 speakers include:

  • Ralf Altmeyer
    Director General, Institut Pasteur Shanghai, Chinese Academy of Sciences
  • Jun Bao
    Senior Vice President and Chief Business Officer, Shenogen Pharma Group
  • Chih-Liang Chin
    Director and Site Lead, Imaging, Merck Singapore
  • Victoria Elegant
    Vice President of Medical & Regulatory Affairs, Baxter, China
  • Frank Grams
    VP, Head Alliance Management & Transactions, Sanofi R&D
  • Jessie Gu
    Head, Translational Medicine China, Novartis Institute for Biomedical Research, China
  • Ming Guo
    Co-Founder & COO, Ascentage Pharma
  • Yariv Hefez
    Vice President Business Development, Portfolio Management, Strategy and Partnering, Biosimilars Unit, Merck
  • Yong-jiang Hei
    Executive Medical Director, Amgen China
  • Ming Ji
    Sr. Medical Director, Medical Safety Evaluation, AbbVie
  • Lei Jiang
    CEO, Shanghai HaiHe Pharmaceutical Co., Ltd
  • Oliver Kong
    Senior Director, Clinical Development Oncology, Celgene Corporation
  • Zheng Li
    General Manager, Head of Research China, Lundbeck
  • Jian Li
    Director, Partnering and External Innovation - Asia Pacific, Sanofi R&D
  • Zhengqing Li
    VP and Head of China Development, MSD
  • Hua Mu
    Senior Vice President, Global Head of Product Development Service and Partnership Business Unit, WuXi AppTec (Shanghai) Co., Ltd
  • Dan Paulson
    Vice President, Global Clinical Development, Group Head, Cardiovascular Risk Management and Women’s HealthCare, Bayer HealthCare Company Limited Global R&D Centre
  • Akhilesh Sharma
    Senior Vice President & Global Head Global Medical Affairs, Dr. Reddy's Laboratories India
  • Jagdev Sidhu
    Senior Director Clinical Pharmacology & Pharmacometrics,CSL Limited
  • Cezary Statuch
    Vice President of R&D, Bristol-Myers Squibb, China
  • Dejun Tang
    Site Head, Biometrics & Statistical Sciences and Methodology, Novartis, China
  • David Tattersall
    Director, Neurodegeneration Parkinson's Disease Group, GSK R&D China Shanghai
  • Yingmei Tu
    Clinical Research Director, Merck
  • Patrecia Valone
    Senior Director, Development Operations, Takeda Development Center Asia and Takeda Shanghai Development Center
  • Mark Wade
    Director, Patient Solutions, Almac
  • Wei Wang
    Associate Director, Safety Surveillance and Risk Management, Pfizer, China
  • Jingsong Wang
    Head of China R&D, Head of Translational Medicine, Asia Pacific Sanofi
  • Jenny Wei
    Head of R&D Information Asia & EM, Innovation Center China, AstraZeneca Global R&D
  • Hank Wu
    Director of IT, Discovery Sciences, Biogen Idec
  • Zhenping Wu
    Senior Vice President, Pharmaceutical Sciences, Hutchison Medi Pharma
  • Yan Wu
    Executive Director, Head of Clinical Operations and Drug Safety, Hutchison Medi Pharma
  • Mingde Xia
    Senior Director, Johnson & Johnson Innovation Center, Asia Pacific
  • Jason Yang
    Senior Vice President, Head of Clinical Development, BeiGene (Beijing) Co., Ltd